Filing Details
- Accession Number:
- 0001104659-20-093991
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-12 17:17:05
- Reporting Period:
- 2020-05-15
- Accepted Time:
- 2020-08-12 17:17:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740947 | John Soriano | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-05-15 | 994 | $25.46 | 78,253 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2020-08-10 | 52,046 | $13.91 | 77,259 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-10 | 52,046 | $30.29 | 25,213 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-10 | 52,046 | $0.00 | 52,046 | $13.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 86,744 | 2029-01-03 | No | 4 | M | Direct |
Footnotes
- Represents the withholding of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. This transaction was not reported previously due to a clerical error.
- This is the weighted average sales price representing 52,046 shares sold at prices ranging from $30.12 to $30.49 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Billionaire Hedge Funds
